Evidence map›Paper›PMID 25821476›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2015

The Synergistic Beneficial Effects of Ginkgo Flavonoid and Coriolus versicolor Polysaccharide for Memory Improvements in a Mouse Model of Dementia.

Xianying Fang, Yan Jiang, Hui Ji, Linguo Zhao, Wei Xiao, Zhenzhong Wang, Gang Ding

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Antioxidants (Basel, Switzerland) · 2024
    Review
  2. Redox Modulation of Meniere Disease byCurrent neuropharmacology · 2024
    Article
  3. Antioxidants, Hormetic Nutrition, and Autism.Current neuropharmacology · 2024
    Review
  4. COVID-19 and Cancer Diseases-The Potential ofInternational journal of molecular sciences · 2023
    Review
  5. Natural Compounds Such asBiomedicines · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Antioxidants (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Oncotarget · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Xianying FangCollege of Chemical Engineering, Nanjing Forestry University, 159 Long Pan Road, Nanjing 210037, China ; Jiangsu Key Laboratory of Biomass Based Green Fuels and Chemicals, 159 Long Pan Road, Nanjing 210037, China.
Yan JiangCollege of Chemical Engineering, Nanjing Forestry University, 159 Long Pan Road, Nanjing 210037, China ; Jiangsu Key Laboratory of Biomass Based Green Fuels and Chemicals, 159 Long Pan Road, Nanjing 210037, China.
Hui JiDepartment of Pharmacology, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
Linguo ZhaoCollege of Chemical Engineering, Nanjing Forestry University, 159 Long Pan Road, Nanjing 210037, China ; Jiangsu Key Laboratory of Biomass Based Green Fuels and Chemicals, 159 Long Pan Road, Nanjing 210037, China.ORCID 0000-0002-8448-3681
Wei XiaoJiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichang South Road, Lianyungang 222001, China.
Zhenzhong WangJiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichang South Road, Lianyungang 222001, China.
Gang DingJiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichang South Road, Lianyungang 222001, China.
Kanion Pharmaceutical (China) · CNNanjing Forestry University · CNChina Pharmaceutical University · CNInstitute of Chemical Industry of Forest Products · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study reports the combination of Ginkgo flavonoid (GF) and Coriolus versicolor polysaccharide (CVP) in the prevention and treatment of a mouse model of Alzheimer's disease (AD). GF is a traditional health product, and CVP is the main active ingredient of the medicinal fungus Coriolus versicolor. The Morris water maze test, the Y maze, and the step-through test showed that the combinational use of CVP and GF synergistically improved memory in a mouse model of AD. Based on H&E staining analysis, the combination of CVP and GF decreased the severity of the pathological findings in the brain. Given that the expression of IL-1β, IL-6, and TNF-α was downregulated, the inflammation response in AD mice was considered to be inhibited. The downregulation of GFAP further demonstrated that inflammation was reduced in the brain of AD mice following treatment. Moreover, the expression levels of superoxide dismutase (SOD) and catalase (CAT) were elevated in the brains of treated mice, indicating that oxidation levels were reduced upon the combination treatment. Our results provide new insights into the efficient utilization of traditional medicine for preventing dementia.

Identifiers

PMID25821476
PMCPMC4364004
OpenAlexW1979178963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.